Report Detail

Other Global Hirudin Market Insights, Forecast to 2025

  • RnM2931869
  • |
  • 12 February, 2019
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Other

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin.

Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
According to the statistical data, Demand cannot be satisfied with supply. Currently, Hirudin market has a certain potential in USA, Europe and Asia Market. These areas demand are rapidly growth.
In recent years in China as the main ingredient to hirudin, there are many kinds of proprietary Chinese medicines, such as cerebral blood oral liquid, tablets thrombosis, blood capsule, with its annual output value of tens of millions. New drugs with leeches are constantly studied and introduced. Genetic engineering of recombinant leech-like peptide drugs to replace or hirudin as anticoagulant drug additives stasis, which can be achieved in the near future. As the injection for the treatment of cardiovascular diseases and cancer drugs, the need for further clinical research. Needless to say, recombinant hirudin-like peptide drug development will bring huge social and economic benefits.
Global Hirudin market size will increase to 4180 Million US$ by 2025, from 3450 Million US$ in 2018, at a CAGR of 2.4% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hirudin.

This report researches the worldwide Hirudin market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Hirudin breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

The following manufacturers are covered in this report:
The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm

Hirudin Breakdown Data by Type
Natural Hirudin
Recombinant Hirudin
Hirudin Breakdown Data by Application
Thrombosis Disease
Tumor Disease
Others

Hirudin Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

Hirudin Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives are:
To analyze and research the global Hirudin capacity, production, value, consumption, status and forecast;
To focus on the key Hirudin manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Hirudin :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    Global Hirudin Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

      1 Study Coverage

      • 1.1 Hirudin Product
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Hirudin Market Size Growth Rate by Type
        • 1.4.2 Natural Hirudin
        • 1.4.3 Recombinant Hirudin
      • 1.5 Market by Application
        • 1.5.1 Global Hirudin Market Size Growth Rate by Application
        • 1.5.2 Thrombosis Disease
        • 1.5.3 Tumor Disease
        • 1.5.4 Others
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Hirudin Production
        • 2.1.1 Global Hirudin Revenue 2014-2025
        • 2.1.2 Global Hirudin Production 2014-2025
        • 2.1.3 Global Hirudin Capacity 2014-2025
        • 2.1.4 Global Hirudin Marketing Pricing and Trends
      • 2.2 Hirudin Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Hirudin Manufacturers
      • 2.4 Market Drivers, Trends and Issues
      • 2.5 Macroscopic Indicator
        • 2.5.1 GDP for Major Regions
        • 2.5.2 Price of Raw Materials in Dollars: Evolution

      3 Market Size by Manufacturers

      • 3.1 Hirudin Production by Manufacturers
        • 3.1.1 Hirudin Production by Manufacturers
        • 3.1.2 Hirudin Production Market Share by Manufacturers
      • 3.2 Hirudin Revenue by Manufacturers
        • 3.2.1 Hirudin Revenue by Manufacturers (2014-2019)
        • 3.2.2 Hirudin Revenue Share by Manufacturers (2014-2019)
      • 3.3 Hirudin Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Hirudin Production by Regions

      • 4.1 Global Hirudin Production by Regions
        • 4.1.1 Global Hirudin Production Market Share by Regions
        • 4.1.2 Global Hirudin Revenue Market Share by Regions
      • 4.2 United States
        • 4.2.1 United States Hirudin Production
        • 4.2.2 United States Hirudin Revenue
        • 4.2.3 Key Players in United States
        • 4.2.4 United States Hirudin Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Hirudin Production
        • 4.3.2 Europe Hirudin Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Hirudin Import & Export
      • 4.4 China
        • 4.4.1 China Hirudin Production
        • 4.4.2 China Hirudin Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Hirudin Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Hirudin Production
        • 4.5.2 Japan Hirudin Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Hirudin Import & Export
      • 4.6 Other Regions
        • 4.6.1 South Korea
        • 4.6.2 India
        • 4.6.3 Southeast Asia

      5 Hirudin Consumption by Regions

      • 5.1 Global Hirudin Consumption by Regions
        • 5.1.1 Global Hirudin Consumption by Regions
        • 5.1.2 Global Hirudin Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Hirudin Consumption by Application
        • 5.2.2 North America Hirudin Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Hirudin Consumption by Application
        • 5.3.2 Europe Hirudin Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Hirudin Consumption by Application
        • 5.4.2 Asia Pacific Hirudin Consumption by Countries
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 South Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Hirudin Consumption by Application
        • 5.5.2 Central & South America Hirudin Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Hirudin Consumption by Application
        • 5.6.2 Middle East and Africa Hirudin Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Hirudin Breakdown Dada by Type
      • 6.2 Global Hirudin Revenue by Type
      • 6.3 Hirudin Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Hirudin Breakdown Dada by Application
        • 7.2.1 Global Hirudin Consumption by Application
        • 7.2.2 Global Hirudin Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 The Medicines Company
        • 8.1.1 The Medicines Company Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Hirudin
        • 8.1.4 Hirudin Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 Keyken
        • 8.2.1 Keyken Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Hirudin
        • 8.2.4 Hirudin Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 Minapharm
        • 8.3.1 Minapharm Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Hirudin
        • 8.3.4 Hirudin Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 Abbott
        • 8.4.1 Abbott Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Hirudin
        • 8.4.4 Hirudin Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 SALUBRIS
        • 8.5.1 SALUBRIS Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Hirudin
        • 8.5.4 Hirudin Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 Pfizer, Inc
        • 8.6.1 Pfizer, Inc Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Hirudin
        • 8.6.4 Hirudin Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 Teva Pharmaceutical Industries Ltd
        • 8.7.1 Teva Pharmaceutical Industries Ltd Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Hirudin
        • 8.7.4 Hirudin Product Description
        • 8.7.5 SWOT Analysis
      • 8.8 DUOPUTAI
        • 8.8.1 DUOPUTAI Company Details
        • 8.8.2 Company Description
        • 8.8.3 Capacity, Production and Value of Hirudin
        • 8.8.4 Hirudin Product Description
        • 8.8.5 SWOT Analysis
      • 8.9 Pentapharm
        • 8.9.1 Pentapharm Company Details
        • 8.9.2 Company Description
        • 8.9.3 Capacity, Production and Value of Hirudin
        • 8.9.4 Hirudin Product Description
        • 8.9.5 SWOT Analysis

      9 Production Forecasts

      • 9.1 Hirudin Production and Revenue Forecast
        • 9.1.1 Global Hirudin Production Forecast 2019-2025
        • 9.1.2 Global Hirudin Revenue Forecast 2019-2025
      • 9.2 Hirudin Production and Revenue Forecast by Regions
        • 9.2.1 Global Hirudin Revenue Forecast by Regions
        • 9.2.2 Global Hirudin Production Forecast by Regions
      • 9.3 Hirudin Key Producers Forecast
        • 9.3.1 United States
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Hirudin Production Forecast by Type
        • 9.4.2 Global Hirudin Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Hirudin Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Hirudin Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Hirudin Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Hirudin Consumption Forecast by Countries 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Hirudin Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Hirudin Consumption Forecast by Countries 2019-2025
        • 10.7.2 Middle East and Africa
        • 10.7.3 Turkey
        • 10.7.4 GCC Countries
        • 10.7.5 Egypt
        • 10.7.6 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Hirudin Upstream Market
        • 11.1.1 Hirudin Key Raw Material
        • 11.1.2 Typical Suppliers of Key Hirudin Raw Material
        • 11.1.3 Hirudin Raw Material Market Concentration Rate
      • 11.2 Hirudin Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Hirudin Distributors
      • 11.5 Hirudin Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
          • 14.1.2 Data Source
        • 14.2 Author Details

        Summary:
        Get latest Market Research Reports on Hirudin . Industry analysis & Market Report on Hirudin is a syndicated market report, published as Global Hirudin Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Hirudin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,900.00
        $5,850.00
        $7,800.00
        3,116.10
        4,674.15
        6,232.20
        3,623.10
        5,434.65
        7,246.20
        602,784.00
        904,176.00
        1,205,568.00
        325,650.00
        488,475.00
        651,300.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report